Literature DB >> 15112362

Diagnosis of intestinal acariasis with avidin-biotin system enzyme-linked immunosorbent assay.

Rong-Bo Zhang1, Yong Huang, Chao-Pin Li, Yu-Bao Cui.   

Abstract

AIM: To explore the value of avidin-biotin system enzyme-linked immunosorbent assay (ABC-ELISA) in diagnosis of intestinal acariasis.
METHODS: Mite-specific IgG levels in serum of 48 patients with intestinal acariasis were measured with ABC-ELISA. The sensitivity of this method was compared with that of staphylococcal protein A enzyme-linked immunosorbent assay (SPA-ELISA).
RESULTS: The positive rate of mite-specific IgG detected with ABC-ELISA and SPA-ELISA was 89.58% (43/48) and 56.25% (27/48), respectively. The positive rate with ABC-ELISA was statistically higher than that with SPA-ELISA (chi2=13.50, P<0.01).
CONCLUSION: ABC-ELISA is an effective method for the diagnosis of intestinal acariasis.

Entities:  

Mesh:

Year:  2004        PMID: 15112362      PMCID: PMC4622786          DOI: 10.3748/wjg.v10.i9.1369

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  A case of pulmonary acariasis in lung of Japanese macaque.

Authors:  E Hiraoka; T Sato; W Shirai; J Kimura; S Nogami; M Itou; K Shimizu
Journal:  J Vet Med Sci       Date:  2001-01       Impact factor: 1.267

2.  Comparison of subcutaneous ivermectin and oral moxidectin for the treatment of notoedric acariasis in hamsters.

Authors:  L Beco; A Petite; T Olivry
Journal:  Vet Rec       Date:  2001-09-15       Impact factor: 2.695

3.  Reactivity to intradermal injection of extracts of Dermatophagoides farinae, Dermatophagoides pteronyssinus, house dust mite mix, and house dust in dogs suspected to have atopic dermatitis: 115 cases (1996-1998).

Authors:  A Hillier; K W Kwochka; L R Pinchbeck
Journal:  J Am Vet Med Assoc       Date:  2000-08-15       Impact factor: 1.936

4.  Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus: a randomized, double-blind, placebo-controlled trial in asthmatic patients.

Authors:  Antonio Basomba; Ana I Tabar; Dolores Hernández F de Rojas; Blanca E García; Remedios Alamar; José M Olaguíbel; Jaime Moscoso del Prado; Santiago Martín; Pilar Rico
Journal:  J Allergy Clin Immunol       Date:  2002-06       Impact factor: 10.793

5.  Enzyme linked immunosorbent assay (ELISA) for the detection of IgG, IgM, IgE and IgA against Cysticercus cellulosae in cerebrospinal fluid of patients with neurocysticercosis.

Authors:  Newton Satoru Odashima; Osvaldo Massaiti Takayanagui; José Fernando de Castro Figueiredo
Journal:  Arq Neuropsiquiatr       Date:  2002-06       Impact factor: 1.420

6.  Local and systemic reactions during immunotherapy with adsorbed extracts of house dust mite in children.

Authors:  N Akçakaya; A Hassanzadeh; Y Camcioğlu; H Cokuğraş
Journal:  Ann Allergy Asthma Immunol       Date:  2000-10       Impact factor: 6.347

7.  A study on the culture medium antigens of Cystcercus cellulosae for detecting antibodies of cysticercosis by means of ABC-ELISA.

Authors:  H Guo; Z F Zhao; D Z Shi
Journal:  Southeast Asian J Trop Med Public Health       Date:  1997       Impact factor: 0.267

8.  A histomorphological study of sarcoptic acariasis in the dog: 19 cases.

Authors:  D O Morris; R W Dunstan
Journal:  J Am Anim Hosp Assoc       Date:  1996 Mar-Apr       Impact factor: 1.023

9.  Molecular analysis of the group 1 and 2 allergens from the house dust mite, Euroglyphus maynei.

Authors:  W Smith; K Mills; L Hazell; B Hart; W Thomas
Journal:  Int Arch Allergy Immunol       Date:  1999-01       Impact factor: 2.749

10.  Murine acariasis: I. Pathological and clinical evidence suggesting cutaneous allergy and wasting syndrome in BALB/c mouse.

Authors:  P Jungmann; J L Guénet; P A Cazenave; A Coutinho; M Huerre
Journal:  Res Immunol       Date:  1996-01
View more
  1 in total

Review 1.  When mites attack: domestic mites are not just allergens.

Authors:  Yubao Cui
Journal:  Parasit Vectors       Date:  2014-08-29       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.